Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells
- PMID: 8890164
- PMCID: PMC452228
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells
Abstract
p50csk is a tyrosine protein kinase (TPK) that represses the activity of Src family TPKs. We previously showed that Csk is a potent negative regulator of antigen receptor signaling in T lymphocytes and that its Src homology (SH) 3 and SH2 domains are required to inhibit these signals. To test the idea that the Csk SH3 and SH2 domains mediate interactions with other cellular proteins, we attempted to identify Csk-associated polypeptides using the yeast two-hybrid system. The results of our experiments demonstrated that Csk physically associates with PEP, a protein tyrosine phosphatase (PTP) expressed in hemopoietic cells. Further analyses revealed that this interaction was mediated by the Csk SH3 domain and by a proline-rich region (PPPLPERTP) in the non-catalytic C-terminal portion of PEP. The association between Csk and PEP was documented in transiently transfected Cos-1 cells and in a variety of cells of hemopoietic lineages, including T cells. Additional analyses demonstrated that the association between Csk and PEP is highly specific. Together, these data indicated that PEP may be an effector and/or a regulator of p50csk in T cells and other hemopoietic cells. Moreover, they allowed the identification of PEP as the first known ligand for the Csk SH3 domain.
Similar articles
-
SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.Mol Cell Biol. 2001 Feb;21(4):1077-88. doi: 10.1128/MCB.21.4.1077-1088.2001. Mol Cell Biol. 2001. PMID: 11158295 Free PMC article.
-
Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.J Biol Chem. 1997 Sep 12;272(37):23455-62. doi: 10.1074/jbc.272.37.23455. J Biol Chem. 1997. PMID: 9287362
-
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.J Exp Med. 1999 Jan 4;189(1):111-21. doi: 10.1084/jem.189.1.111. J Exp Med. 1999. PMID: 9874568 Free PMC article.
-
The Src and Csk families of tyrosine protein kinases in hemopoietic cells.Semin Immunol. 1995 Aug;7(4):207-26. doi: 10.1006/smim.1995.0026. Semin Immunol. 1995. PMID: 8520026 Review.
-
C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.Growth Factors. 2005 Sep;23(3):233-44. doi: 10.1080/08977190500178877. Growth Factors. 2005. PMID: 16243715 Review.
Cited by
-
The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human.J Immunol. 2015 Apr 1;194(7):2977-84. doi: 10.4049/jimmunol.1403034. J Immunol. 2015. PMID: 25795788 Free PMC article. Review.
-
Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.J Clin Invest. 2002 Jan;109(1):9-14. doi: 10.1172/JCI14794. J Clin Invest. 2002. PMID: 11781344 Free PMC article. Review. No abstract available.
-
Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling.Mol Cell Biol. 2000 Apr;20(8):2743-54. doi: 10.1128/MCB.20.8.2743-2754.2000. Mol Cell Biol. 2000. PMID: 10733577 Free PMC article.
-
Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach.J Clin Med. 2019 Mar 12;8(3):347. doi: 10.3390/jcm8030347. J Clin Med. 2019. PMID: 30871019 Free PMC article.
-
PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling.Sci Signal. 2020 Mar 17;13(623):eaaw8130. doi: 10.1126/scisignal.aaw8130. Sci Signal. 2020. PMID: 32184287 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous